Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
Fourth Circuit Highlights Tougher Path to Dismissal of FCA Cases Post-SuperValuMarch 18, 2026Sidley Secures Early Termination of Corporate Probation in Clean Air Act Matter for Leading Aftermarket Automotive CompanyMarch 16, 2026U.S. DOJ Implements Uniform Corporate Enforcement and Voluntary Self-Disclosure Framework Across All Components Except AntitrustMarch 16, 2026Fifth Circuit Panel Produces Three Opinions Wrestling with Application of First to File BarMarch 13, 2026Sidley Partner Lisa Miller to Speak at the 2026 WWCDA Annual Attorney Meeting in San DiegoWednesday, March 11, 2026Sidley Lawyers Karen Popp, Kristin Graham Koehler, and Lisa Miller to Speak at the ABA's 2026 White Collar Crime Institute in San DiegoTuesday, March 10 – Friday, March 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory